Literature DB >> 22057244

Environmental factors and rheumatic heart disease in Fiji.

Joelle Dobson1, Andrew C Steer, Samantha Colquhoun, Joseph Kado.   

Abstract

Rheumatic heart disease (RHD) is an important cause of cardiac morbidity and mortality globally, particularly in the Pacific region. Susceptibility to RHD is thought to be due to genetic factors that are influenced by environmental factors, such as crowding and poverty. However, there are few data relating to these environmental factors in the Pacific region. We conducted a case-control study of 80 cases of RHD with age- and sex-matched controls in Fiji using a questionnaire to investigate associations of RHD with a number of environmental factors. There was a trend toward increased risk of RHD in association with poor-quality housing and lower socioeconomic status, but only one factor, maternal unemployment, reached statistical significance (OR 2.6, 95% confidence interval 1.2-5.8). Regarding crowding, little difference was observed between the two groups. Although our data do not allow firm conclusions, they do suggest that further studies of socioeconomic factors and RHD in the Pacific are warranted. They also suggest that genetic studies would provide an insight into susceptibility to RHD in this population.

Entities:  

Mesh:

Year:  2011        PMID: 22057244     DOI: 10.1007/s00246-011-0139-x

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  20 in total

1.  Influence of socio-economic and other factors on rheumatic fever occurrence.

Authors:  H Vlajinac; B Adanja; J Marinković; M Jarebinski
Journal:  Eur J Epidemiol       Date:  1991-11       Impact factor: 8.082

Review 2.  Towards understanding the pathogenesis of rheumatic fever.

Authors:  J R Carapetis; B J Currie; M F Good
Journal:  Scand J Rheumatol       Date:  1996       Impact factor: 3.641

3.  Survey of rheumatic heart disease in school children of Kinshasa town.

Authors:  B Longo-Mbenza; M Bayekula; R Ngiyulu; V E Kintoki; N F Bikangi; K V Seghers; L E Lukoki; M F Mandundu; M Manzanza; Y Nlandu
Journal:  Int J Cardiol       Date:  1998-02-28       Impact factor: 4.164

Review 4.  The global burden of group A streptococcal diseases.

Authors:  Jonathan R Carapetis; Andrew C Steer; E Kim Mulholland; Martin Weber
Journal:  Lancet Infect Dis       Date:  2005-11       Impact factor: 25.071

5.  Studies in the epidemiology and preventability of rheumatic fever. II. Socio-economic factors and the incidence of acute attacks.

Authors:  L Gordis; A Lilienfeld; R Rodriguez
Journal:  J Chronic Dis       Date:  1969-02

6.  Socioeconomic factors in the etiology of rheumatic fever.

Authors:  B Adanja; H Vlajinac; M Jarebinski
Journal:  J Hyg Epidemiol Microbiol Immunol       Date:  1988

Review 7.  The primary prevention of rheumatic fever.

Authors:  Melissa Kerdemelidis; Diana R Lennon; Bruce Arroll; Briar Peat; Jonathan Jarman
Journal:  J Paediatr Child Health       Date:  2010-09       Impact factor: 1.954

Review 8.  Some of the people, some of the time: susceptibility to acute rheumatic fever.

Authors:  Penelope A Bryant; Roy Robins-Browne; Jonathan R Carapetis; Nigel Curtis
Journal:  Circulation       Date:  2009-02-10       Impact factor: 29.690

9.  Acute rheumatic fever and rheumatic heart disease in Fiji: prospective surveillance, 2005-2007.

Authors:  Andrew C Steer; Joseph Kado; Adam W J Jenney; Michael Batzloff; Lepani Waqatakirewa; E Kim Mulholland; Jonathan R Carapetis
Journal:  Med J Aust       Date:  2009-02-02       Impact factor: 7.738

10.  Socio-economic factors and rheumatic fever occurrence. Differences between patients with and without frequent sore throat.

Authors:  H Vlajinac; B Adanja; M Jarebinski
Journal:  J Hyg Epidemiol Microbiol Immunol       Date:  1989
View more
  7 in total

Review 1.  T cell subsets: an integral component in pathogenesis of rheumatic heart disease.

Authors:  Devinder Toor; Neha Sharma
Journal:  Immunol Res       Date:  2018-02       Impact factor: 2.829

2.  Association of angiotensin I-converting enzyme gene insertion/deletion polymorphism with rheumatic heart disease in Indian population and meta-analysis.

Authors:  Usha Gupta; Avshesh Mishra; Saurabh S Rathore; S K Agarwal; Shantanu Pande; Naveen Garg; Balraj Mittal
Journal:  Mol Cell Biochem       Date:  2013-06-08       Impact factor: 3.396

3.  IL10 Promoter Polymorphisms are Associated with Rheumatic Heart Disease in Saudi Arabian Patients.

Authors:  Atiyeh M Abdallah; Aisha Alnuzha; Abdulhadi H Al-Mazroea; Amr E Eldardear; Ala Y AlSamman; Yousef Almohammadi; Khalid M Al-Harbi
Journal:  Pediatr Cardiol       Date:  2015-08-09       Impact factor: 1.655

Review 4.  Risk Factors for Acute Rheumatic Fever: Literature Review and Protocol for a Case-Control Study in New Zealand.

Authors:  Michael G Baker; Jason Gurney; Jane Oliver; Nicole J Moreland; Deborah A Williamson; Nevil Pierse; Nigel Wilson; Tony R Merriman; Teuila Percival; Colleen Murray; Catherine Jackson; Richard Edwards; Lyndie Foster Page; Florina Chan Mow; Angela Chong; Barry Gribben; Diana Lennon
Journal:  Int J Environ Res Public Health       Date:  2019-11-15       Impact factor: 3.390

5.  Socioeconomic and environmental risk factors among rheumatic heart disease patients in Uganda.

Authors:  Emmy Okello; Barbara Kakande; Elias Sebatta; James Kayima; Monica Kuteesa; Boniface Mutatina; Wilson Nyakoojo; Peter Lwabi; Charles K Mondo; Richard Odoi-Adome; Freers Juergen
Journal:  PLoS One       Date:  2012-08-27       Impact factor: 3.240

Review 6.  The role of social determinants of health in the risk and prevention of group A streptococcal infection, acute rheumatic fever and rheumatic heart disease: A systematic review.

Authors:  Pasqualina M Coffey; Anna P Ralph; Vicki L Krause
Journal:  PLoS Negl Trop Dis       Date:  2018-06-13

7.  Screening Rheumatic Heart Disease in 1530 New Caledonian Adolescents.

Authors:  Jean-Claude Chatard; Thomas Dubois; Florian Espinosa; Joël Kamblock; Pierre-Henri Ledos; Emmanuel Tarpinian; Antoine Da Costa
Journal:  J Am Heart Assoc       Date:  2020-04-26       Impact factor: 5.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.